For Injection: 20 mg and 30 mg of enfortumab vedotin-ejfv as a lyophilized powder in a single-dose vial for reconstitution. (3) None. (4) • Hyperglycemia: Diabetic ketoacidosis may occur in...
DailyMed - PADCEV EJFV- enfortumab vedotin injection, …
2024年8月1日 · For Injection: 20 mg and 30 mg of enfortumab vedotin-ejfv as a lyophilized powder in a single-dose vial for reconstitution.
PADCEV® (enfortumab vedotin-ejfv) for Advanced Bladder Cancer
PADCEV is a prescription medicine used to treat adults with bladder cancer and cancers of the urinary tract (renal pelvis, ureter or urethra) that has spread or cannot be removed by surgery. • PADCEV may be used with pembrolizumab (also known as Keytruda®), or. • PADCEV may be used alone if you:
Enfortumab Vedotin Dosage Guide + Max Dose, Adjustments - Drugs.com
2024年10月4日 · Detailed Enfortumab Vedotin dosage information for adults. Includes dosages for Urothelial Carcinoma; plus renal, liver and dialysis adjustments.
Enfortumab vedotin Uses, Side Effects & Warnings - Drugs.com
Enfortumab vedotin is used to treat cancer of the bladder or urinary tract that has spread to other parts of the body (metastatic), or cannot be removed with surgery. Enfortumab vedotin is usually given after other treatments such as immunotherapy and platinum cancer medicine, or if you are unable to receive platinum cancer medicine.
Enfortumab Vedotin-ejfv Monograph for Professionals - Drugs.com
Reconstitute vial containing 20 or 30 mg of enfortumab vedotin with 2.3 or 3.3 mL, respectively, of sterile water for injection to provide a solution containing 10 mg/mL; direct diluent toward the wall of the vial. Gently swirl vial and allow solution to stand for at least 1 minute to allow bubbles to dissipate. Do not shake reconstituted solution.
enfortumab vedotin (Rx) - Medscape Drugs & Diseases
Medscape - Urothelial carcinoma dosing for (Padcev) enfortumab vedotin, frequency-based adverse effects, comprehensive interactions, contraindications, pregnancy & lactation schedules, and...
Padcev 20 mg powder for concentrate for solution for infusion
2024年11月11日 · Enfortumab vedotin as monotherapy. Previously treated locally advanced or metastatic urothelial cancer. EV-301
Enfortumab vedotin-ejfv Injection - MedlinePlus
Enfortumab vedotin-ejfv injection is used alone or in combination with pembrolizumab (Keytruda) to treat urothelial cancer (cancer of the lining of the bladder and other parts of the urinary tract) that has spread to nearby tissues or other parts of the body or cannot be removed by surgery, and has worsened after treatment with other ...
DCEV® (enfortumab vedotin-ejfv) for injection, for intraven. e severe and fatal cutaneous adverse reactions, including Stevens-Johnson syndrome (SJS) and Toxic Epidermal Necrolysis ( a...
- 某些结果已被删除